PHarmacogenomic Assessment of Cisplatin-Based Chemotherapy Outcomes in Ovarian Cancer

201445 citationsJournal Article

Authors

D. V. Khokhrin · Institute of Molecular Genetics

Alexey Moisseev · Central Bank of the Russian Federation

Limborskaia Sa · Institute of Molecular Genetics

Abstract

The results obtained suggest that SNPs in different genes involved in drug metabolism can be important in identifying patients at risk for nonresponse to or toxicity from cisplatin-based treatment.

Topics & Keywords

Pharmacogenetics and Drug Metabolism Genomics, phytochemicals, and oxidative stress Glutathione Transferases and Polymorphisms

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Pharmacogenomics

Volume 15, Issue 3, pp. 329-337

DOI: 10.2217/pgs.13.237

Field-Weighted Citation Impact: 5.74